SOONNEW ($SOON) fluctuates 111.8% in 24 hours: abnormal buying volume drives price rebound
Bitget Pulse2026/04/17 17:03Volatility Overview
In the past 24 hours, SOONNEW's price rebounded from a low of $0.1521 to a high of $0.3221, currently reporting at $0.2225, marking a fluctuation amplitude of 111.8%. Trading volume surged significantly, with certain periods showing abnormal buying activity driving the rebound.
Brief Analysis of Market Movements
- Abnormal buying volume is the main driver: In the past 24 hours, the price surged rapidly from the low point supported by high trading volume, with no clear news events or official announcements.
- On-chain data remains calm: No significant large transfers, supply changes, or whale activity recorded.
Market Perspectives and Outlook
Market sentiment is leaning short-term bullish. Traders are focusing on the surge in trading volume and technical indicators (such as RSI overbought, MACD turning bullish). It is advised to wait for a pullback before entering, but high volatility risks and potential profit-taking pressure are emphasized.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.
Fed Officials Turn Hawkish: Daly Says Supply Shocks Should No Longer Be "Wait-and-See," Hammack Suggests More Aggressive Rate Hikes May Be Needed if Inflation Expectations Become Entrenched
San Francisco Fed President Daly stated that the traditional "wait and see" approach to supply-side shocks has been abandoned, noting that businesses in her district are tending to pass rising costs on to consumers and that current inflation risks are "skewed fully to the upside." Cleveland Fed President Hammack said that once the public forms an "inflationary mindset," the difficulty of monetary policy regulation will increase significantly, and the required interest rate hikes will then exceed expectations.
Australian Dollar crumbles as job losses shatter RBA rate hike hopes
Over $10 billion in market value evaporated in four trading days as CoreWeave (CRWV.US) debt risks trigger sell-off, but Deutsche Bank sees it as a buying opportunity
Deutsche Bank believes that the recent sell-off of CoreWeave lacks sufficient company fundamentals to justify it, and the sharp price correction has instead created a buying opportunity for investors.
